A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a prospective, randomized, placebo-controlled, double-blind, multi-center parallel- design study to evaluate the effect of BL NCC3001 in subjects with Irritable Bowel Syndrome.
Epistemonikos ID: 22533c898aaa029fea2d17c901efeff5a273a222
First added on: May 09, 2024